MDxHealth (MDXH) Return on Capital Employed (2022 - 2026)

MDxHealth has reported Return on Capital Employed for 5 years, with the latest figure at 20.94% in Q1 2026.

• Quarterly Return on Capital Employed fell 247.0% year-over-year to 20.94% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 20.94% (down 247.0% YoY) and the FY2025 annual result came in at 58.75%, down 3417.0% from the prior year.
• Return on Capital Employed slipped to 20.94% in Q1 2026 per MDXH's latest filing, from 20.59% in the prior quarter.
• Over five years, Return on Capital Employed peaked at 0.04% in Q2 2025 and troughed at 77.73% in Q3 2025.
• A 5-year average of 28.53% and a median of 24.17% in 2024 frame the typical range for Return on Capital Employed.
• The widest YoY moves for Return on Capital Employed: up 3065 bps in 2025, down 5094 bps in 2025.
• Over 5 years, Return on Capital Employed stood at 20.37% in 2022, then slumped by 62 bps to 33.05% in 2023, then soared by 35 bps to 21.55% in 2024, then rose by 4 bps to 20.59% in 2025, then retreated by 2 bps to 20.94% in 2026.
• According to Business Quant data, Return on Capital Employed over the past three periods registered 20.94%, 20.59%, and 77.73% for Q1 2026, Q4 2025, and Q3 2025 respectively.